LTB4DH Polyclonal Antibody

    • Catalog No.:YT2597
    • Applications:WB;ELISA
    • Reactivity:Human;Rat;Mouse;
      • Target:
      • LTB4DH
      • Gene Name:
      • PTGR1
      • Protein Name:
      • Prostaglandin reductase 1
      • Human Swiss Prot No:
      • Q14914
      • Mouse Swiss Prot No:
      • Q91YR9
      • Immunogen:
      • The antiserum was produced against synthesized peptide derived from human PTGR1. AA range:75-124
      • Specificity:
      • LTB4DH Polyclonal Antibody detects endogenous levels of LTB4DH protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • WB 1:500 - 1:2000. ELISA: 1:5000. Not yet tested in other applications.
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • PTGR1;LTB4DH;Prostaglandin reductase 1;PRG-1;15-oxoprostaglandin 13-reductase;NADP-dependent leukotriene B4 12-hydroxydehydrogenase
      • Observed Band(KD):
      • 36kD
      • Background:
      • This gene encodes an enzyme that is involved in the inactivation of the chemotactic factor, leukotriene B4. The encoded protein specifically catalyzes the NADP+ dependent conversion of leukotriene B4 to 12-oxo-leukotriene B4. A pseudogene of this gene is found on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2009],
      • Function:
      • catalytic activity:11-alpha-hydroxy-9,15-dioxoprost-5-enoate + NAD(P)(+) = (5Z)-(13E)-11-alpha-hydroxy-9,15-dioxoprosta-5,13-dienoate + NAD(P)H.,catalytic activity:n-alkanal + NAD(P)(+) = alk-2-enal + NAD(P)H.,function:Functions as 15-oxo-prostaglandin 13-reductase and acts on 15-oxo-PGE1, 15-oxo-PGE2 and 15-oxo-PGE2-alpha. Has no activity towards PGE1, PGE2 and PGE2-alpha (By similarity). Catalyzes the conversion of leukotriene B4 into its biologically less active metabolite, 12-oxo-leukotriene B4. This is an initial and key step of metabolic inactivation of leukotriene B4.,similarity:Belongs to the NADP-dependent oxidoreductase L4BD family.,subunit:Monomer or homodimer.,tissue specificity:High expression in the kidney, liver, and intestine but not in leukocytes.,
      • Subcellular Location:
      • Cytoplasm .
      • Expression:
      • High expression in the kidney, liver, and intestine but not in leukocytes.
      • Products Images
      • Western Blot analysis of various cells using LTB4DH Polyclonal Antibody
      • Western blot analysis of lysates from HT-29 cells, using PTGR1 Antibody. The lane on the right is blocked with the synthesized peptide.
      • Western blot analysis of the lysates from 293 cells using PTGR1 antibody.